These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17214602

  • 1. The many faces of H89: a review.
    Lochner A, Moolman JA.
    Cardiovasc Drug Rev; 2006; 24(3-4):261-74. PubMed ID: 17214602
    [Abstract] [Full Text] [Related]

  • 2. H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition.
    Inoue H, Hase K, Segawa A, Takita T.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):170-7. PubMed ID: 23810683
    [Abstract] [Full Text] [Related]

  • 3. H89, an inhibitor of PKA and MSK, inhibits cyclic-AMP response element binding protein-mediated MAPK phosphatase-1 induction by lipopolysaccharide.
    Cho IJ, Woo NR, Shin IC, Kim SG.
    Inflamm Res; 2009 Dec 15; 58(12):863-72. PubMed ID: 19547917
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation Changes in Response to Kinase Inhibitor H89 in PKA-Null Cells.
    Limbutara K, Kelleher A, Yang CR, Raghuram V, Knepper MA.
    Sci Rep; 2019 Feb 26; 9(1):2814. PubMed ID: 30808967
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase A inhibitor, H89, enhances survival and clonogenicity of dissociated human embryonic stem cells through Rho-associated coiled-coil containing protein kinase (ROCK) inhibition.
    Zhang L, Xu Y, Xu J, Wei Y, Xu X.
    Hum Reprod; 2016 Apr 26; 31(4):832-43. PubMed ID: 26848187
    [Abstract] [Full Text] [Related]

  • 6. H89 (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) induces reduction of myosin regulatory light chain phosphorylation and inhibits cell proliferation.
    Umeda D, Yamada K, Tachibana H.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):61-6. PubMed ID: 18579130
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibility of Plasmodium falciparum cyclic AMP-dependent protein kinase and its mammalian homologue to the inhibitors.
    Sudo A, Kato K, Kobayashi K, Tohya Y, Akashi H.
    Mol Biochem Parasitol; 2008 Aug 20; 160(2):138-42. PubMed ID: 18501980
    [Abstract] [Full Text] [Related]

  • 9. H89, an inhibitor of protein kinase A (PKA), stimulates Na+ transport by translocating an epithelial Na+ channel (ENaC) in fetal rat alveolar type II epithelium.
    Marunaka Y, Niisato N.
    Biochem Pharmacol; 2003 Sep 15; 66(6):1083-9. PubMed ID: 12963496
    [Abstract] [Full Text] [Related]

  • 10. Analysis of inhibition by H89 of UCP1 gene expression and thermogenesis indicates protein kinase A mediation of beta(3)-adrenergic signalling rather than beta(3)-adrenoceptor antagonism by H89.
    Fredriksson JM, Thonberg H, Ohlson KB, Ohba K, Cannon B, Nedergaard J.
    Biochim Biophys Acta; 2001 Apr 23; 1538(2-3):206-17. PubMed ID: 11336791
    [Abstract] [Full Text] [Related]

  • 11. Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth.
    Kurokawa H, Kato K, Iwanaga T, Sugi T, Sudo A, Kobayashi K, Gong H, Takemae H, Recuenco FC, Horimoto T, Akashi H.
    PLoS One; 2011 Apr 23; 6(7):e22492. PubMed ID: 21799871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opposite effects of two PKA inhibitors on cAMP inhibition of IGF-I-induced oligodendrocyte development: a problem of unspecificity?
    Palacios N, Sánchez-Franco F, Fernández M, Sánchez I, Villuendas G, Cacicedo L.
    Brain Res; 2007 Oct 31; 1178():1-11. PubMed ID: 17920050
    [Abstract] [Full Text] [Related]

  • 15. cAMP-Induced Histones H3 Dephosphorylation Is Independent of PKA and MAP Kinase Activations and Correlates With mTOR Inactivation.
    Rodriguez P, Rojas J.
    J Cell Biochem; 2016 Mar 31; 117(3):741-50. PubMed ID: 26335579
    [Abstract] [Full Text] [Related]

  • 16. cAMP-PKA signaling pathway regulates bone resorption mediated by processing of cathepsin K in cultured mouse osteoclasts.
    Park YG, Kim YH, Kang SK, Kim CH.
    Int Immunopharmacol; 2006 Jun 31; 6(6):947-56. PubMed ID: 16644480
    [Abstract] [Full Text] [Related]

  • 17. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
    Riva L, Song OR, Prentoe J, Helle F, L'homme L, Gattolliat CH, Vandeputte A, Fénéant L, Belouzard S, Baumert TF, Asselah T, Bukh J, Brodin P, Cocquerel L, Rouillé Y, Dubuisson J.
    J Virol; 2018 May 15; 92(10):. PubMed ID: 29491159
    [Abstract] [Full Text] [Related]

  • 18. Use of pseudosubstrate affinity to measure active protein kinase A.
    Paulucci-Holthauzen AA, O'Connor KL.
    Anal Biochem; 2006 Aug 15; 355(2):175-82. PubMed ID: 16842735
    [Abstract] [Full Text] [Related]

  • 19. Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin's receptor LRP1.
    Zhang W, Guo H, Jing H, Li Y, Wang X, Zhang H, Jiang L, Ren F.
    J Bone Miner Res; 2014 Aug 15; 29(5):1232-43. PubMed ID: 24877241
    [Abstract] [Full Text] [Related]

  • 20. Effect of protein kinase C and protein kinase A inhibitors on contraction of isolated femoral arteries of SHR and Wistar rats.
    Bal MS, Paulis L, Zicha J, Kunes J.
    Physiol Res; 2009 Aug 15; 58(6):793-798. PubMed ID: 19093737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.